CAS: 132741-31-2; 3,5-Difluoromandelic Acid

该化合物是一种芳烃式的碳酸,其特点是,在甲氧酸结构的3和5个位置上存在两个氟原子,这种化合物的特点是,一个碳附带一个联苯组,既含有氢氧基(OH),又含有一种碳的碳,有助于其酸性能.引入氟芳原子会增强化合物的极度,并能够影响其在各种溶剂中的再活性和溶解性.一般来说,这种氟化合物与非氟化的对等物相比,其稳定性和生物活动会增加,并发生变化.3,5-二氟二氟二苯基酸可能用于有机合成和制药用途,特别是用于开发氟化药物或作为化学反应的中间体.其独特的结构特征使它成为医药化学和材料科学的一个主题.与许多氟化合物一样,由于潜在的毒性和环境影响,应观测到安全和处理预防措施.

结构式图片

相似化合物

794566-88-4 208259-37-4 209982-92-3

欧盟法规

C&L通报

上下游产品

CAS号32085-88-4 3,5-二氟苯甲醛

合成工艺路线路线简述

  • 合成目标产物 3,5-Difluoromandelic Acid 主要起始原料 3,5-Difluorobenzaldehyde
  • (文献来源)合成步骤主要原料 3,5-Difluorobenzaldehyde
📜3,5-二氟苯甲醛置于盐酸,水,Sodium Hydrogensulfite体系中,用 1,4-二氧六环,乙醚 用作溶剂,化学反应 8.0H,反应生成3,5-二氟扁桃酸
参考文献:脂肪酶ps-30催化的立体选择性酰化反应对扁桃酸酯的动力学拆分
标题:脂肪酶ps-30催化的立体选择性酰化反应对扁桃酸酯的动力学拆分
摘要:通过使用脂肪酶ps-30作为催化剂,已通过立体选择性酰化反应实现了一系列外消旋扁桃酸酯的动力学拆分.动力学对映体比率(e)的值达到197.5.简要讨论了取代基的作用.
Doi:10.1016/j.Tetlet.2014.02.095

海关参考信息

专利信息


专利号:US-6774125-B2
优先权日:1998-06-22
标 题:Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
发明人:AUDIA JAMES E; THOMPSON RICHARD C; WILKIE STEPHEN C; BRITTON THOMAS C; PORTER WARREN J; HUFFMAN GEORGE W; LATIMER LEE H
权利人:ELAN PHARM INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:US-6509331-B1
优先权日:1998-06-22
标题:Deoxyamino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
发明人:AUDIA JAMES E; THOMPSON RICHARD C; WILKIE STEPHEN C; BRITTON THOMAS C; PORTER WARREN J; HUFFMAN GEORGE W; LATIMER LEE H
权利人:ELAN PHARM INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit beta-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits beta-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:US-6849650-B2
优先权日:1998-02-27
标 题:Heterocyclic compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
发明人:THORSETT EUGENE D; PORTER WARREN J; NISSEN JEFFREY S; LATIMER LEE H; AUDIA JAMES E; DROSTE JAMES
权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:EP-0951466-B1
优先权日:1996-12-23
标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
发明人:WU JING; TUNG JAY S; THORSETT EUGENE D; PLEISS MICHAEL A; NISSEN JEFFREY S; NEITZ JEFFREY; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES E; REEL JON K; MABRY THOMAS E; DRESSMAN BRUCE A; CWI CYNTHIA L; DROSTE JAMES J; HENRY STEVEN S; MCDANIEL STACEY L; SCOTT WILLIAM L; STUCKY RUSSELL D
权利人:ELAN PHARM INC; LILLY CO ELI
摘要:Disclosed are compounds for Formula (I) wherein the substituents are as defined in the claims which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:US-7390801-B2
优先权日:1996-12-23
标题:Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
发明人:THORSETT EUGENE D; PLEISS MICHAEL A; LATIMER LEE H; JOHN VARGHESE; FREEDMAN STEPHEN; BRITTON THOMAS C; AUDIA JAMES A; REEL JON K; DRESSMAN BRUCE A; DROSTE JAMES J; HENRY STEVEN S; STUCKY RUSSELL D; PORTER WARREN J
权利人:ATHENA NEUROSCIENCES INC; LILLY CO ELI
摘要:Disclosed are compounds which inhibit β-amyloid peptide release and/or its synthesis, and, accordingly, have utility in treating Alzheimer's disease. Also disclosed are pharmaceutical compositions comprising a compound which inhibits β-amyloid peptide release and/or its synthesis as well as methods for treating Alzheimer's disease both prophylactically and therapeutically with such pharmaceutical compositions.

专利号:WO-0134571-A1
优先权日:1999-11-09
标题:β-AMINOACID COMPOUNDS USEFUL FOR INHIBITING β-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS
发明人:AUDIA JAMES EDMUND; PORTER WARREN JAYE; SCOTT WILLIAM LEONARD; STACK DOUGLAS RICHARD; THOMPSON RICHARD CRAIG
权利人:LILLY CO ELI; AUDIA JAMES EDMUND; PORTER WARREN JAYE; SCOTT WILLIAM LEONARD; STACK DOUGLAS RICHARD; THOMPSON RICHARD CRAIG
摘要:The present invention relates β-aminoacid containing compounds of formula (I) which inhibit β-amyloid peptide release and/or its synthesis and are useful in treating Alzheimer's disease and cognition enhancement.

供应商参考报价(招募中)

品牌试剂参考报价(招募中)

📌 第三方产品分析报告

✅ COA系统入驻 | 共享模式

合成参考文献


摘要:Parmeggiani, F.; Galman, J. L.; Montgomery, S. L.; Turner, N. J., Science of Synthesis, (2019) , 403.
📝 需求与反馈
尽可能描述清楚需求与问题信息
×

通知